Literature DB >> 22882894

Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

William J McCarthy1, Rafael Meza, Jihyoun Jeon, Suresh H Moolgavkar.   

Abstract

In this chapter we review the epidemiology of lung cancer incidence and mortality among never smokers/nonsmokers and describe the never smoker lung cancer risk models used by the Cancer Intervention and Surveillance Network (CISNET) modelers. Our review focuses on those influences likely to have measurable population impact on never smoker risk, such as secondhand smoke, even though the individual-level impact may be small. Occupational exposures may also contribute importantly to the population attributable risk of lung cancer. We examine the following risk factors in this chapter: age, environmental tobacco smoke, cooking fumes, ionizing radiation including radon gas, inherited genetic susceptibility, selected occupational exposures, preexisting lung disease, and oncogenic viruses. We also compare the prevalence of never smokers between the three CISNET smoking scenarios and present the corresponding lung cancer mortality estimates among never smokers as predicted by a typical CISNET model.
© 2012 Society for Risk Analysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22882894      PMCID: PMC3485693          DOI: 10.1111/j.1539-6924.2012.01768.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  110 in total

1.  Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies.

Authors:  S Darby; D Hill; A Auvinen; J M Barros-Dios; H Baysson; F Bochicchio; H Deo; R Falk; F Forastiere; M Hakama; I Heid; L Kreienbrock; M Kreuzer; F Lagarde; I Mäkeläinen; C Muirhead; W Oberaigner; G Pershagen; A Ruano-Ravina; E Ruosteenoja; A Schaffrath Rosario; M Tirmarche; L Tomásek; E Whitley; H-E Wichmann; R Doll
Journal:  BMJ       Date:  2004-12-21

2.  Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

3.  Trans, trans-2,4-decadienal, a product found in cooking oil fumes, induces cell proliferation and cytokine production due to reactive oxygen species in human bronchial epithelial cells.

Authors:  Louis W Chang; Wai-Sze Lo; Pinpin Lin
Journal:  Toxicol Sci       Date:  2005-07-13       Impact factor: 4.849

4.  Erlotinib in previously treated non-small-cell lung cancer.

Authors:  Frances A Shepherd; José Rodrigues Pereira; Tudor Ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

5.  Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).

Authors:  Nick Thatcher; Alex Chang; Purvish Parikh; José Rodrigues Pereira; Tudor Ciuleanu; Joachim von Pawel; Sumitra Thongprasert; Eng Huat Tan; Kristine Pemberton; Venice Archer; Kevin Carroll
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

Review 6.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.

Authors:  Ann G Schwartz; John C Ruckdeschel
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

7.  Genotoxicity and oxidative stress of the mutagenic compounds formed in fumes of heated soybean oil, sunflower oil and lard.

Authors:  Cheng-Huang Dung; She-Ching Wu; Gow-Chin Yen
Journal:  Toxicol In Vitro       Date:  2005-10-10       Impact factor: 3.500

Review 8.  Does interstitial lung disease predispose to lung cancer?

Authors:  Craig E Daniels; James R Jett
Journal:  Curr Opin Pulm Med       Date:  2005-09       Impact factor: 3.155

9.  Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma.

Authors:  Ichiro Yoshino; Daigo Kawano; Taro Oba; Koji Yamazaki; Takuro Kometani; Yoshihiko Maehara
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

10.  Multistage carcinogenesis and lung cancer mortality in three cohorts.

Authors:  William D Hazelton; Mark S Clements; Suresh H Moolgavkar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

View more
  26 in total

1.  Confluent impact of housing and geology on indoor radon concentrations in Atlanta, Georgia, United States.

Authors:  Dajun Dai; Fredrick B Neal; Jeremy Diem; Daniel M Deocampo; Christine Stauber; Timothy Dignam
Journal:  Sci Total Environ       Date:  2019-02-20       Impact factor: 7.963

2.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

3.  Survey Mode and Rates of Smoke-free Homes and Support for Smoking Bans Among Single Parents in the United States in 2010-2011 and 2014-2015.

Authors:  Trung Ha; Julia N Soulakova
Journal:  Surv Pract       Date:  2018-04-16

4.  Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Authors:  Kevin Ten Haaf; Harry J de Koning
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

Review 5.  [Lung cancer screening - risk stratification : Who should undergo screening?].

Authors:  L Beer; H Prosch
Journal:  Radiologe       Date:  2016-09       Impact factor: 0.635

6.  Chapter 5: Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation.

Authors:  Jihyoun Jeon; Rafael Meza; Martin Krapcho; Lauren D Clarke; Jeff Byrne; David T Levy
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

7.  The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.

Authors:  Ting-Yuan David Cheng; Susanna M Cramb; Peter D Baade; Danny R Youlden; Chukwumere Nwogu; Mary E Reid
Journal:  J Thorac Oncol       Date:  2016-06-27       Impact factor: 15.609

8.  Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.

Authors:  Abbie Begnaud; Ping Yang; Camille Robichaux; Nathan Rubin; Robert Kratzke; Anne Melzer; Constantin Aliferis; Pamala Jacobson
Journal:  Clin Lung Cancer       Date:  2019-10-30       Impact factor: 4.785

9.  The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants.

Authors:  Randa A El-Zein; Carol J Etzel; Reginald F Munden
Journal:  Transl Lung Cancer Res       Date:  2018-06

10.  Protective Effects of Thymoquinone, an Active Compound of Nigella sativa, on Rats with Benzo(a)pyrene-Induced Lung Injury through Regulation of Oxidative Stress and Inflammation.

Authors:  Mohammad A Alzohairy; Amjad Ali Khan; Mohammed A Alsahli; Saleh A Almatroodi; Arshad Husain Rahmani
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.